Omalizumab Improves Efficacy of Oral Immunotherapy for Multiple Food Allergies

Combining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves the efficacy of OIT for children with allergies to multiple foods, new clinical trial findings show. After 36 weeks, more than 80 per cent of children who received omalizumab and OIT could safely consume two-gram portions of at least two [...]

By |2017-12-13T10:24:17+00:00December 13th, 2017|Community Pharmacy|Comments Off on Omalizumab Improves Efficacy of Oral Immunotherapy for Multiple Food Allergies

Steroid Study Sheds Light on Long-Term Side-Effects of Medicines

Fresh insights into key hormones found in commonly prescribed medicines have been discovered, providing further understanding of their side-effects. The study in immune cells may help to explain why some people develop resistance to these drugs, which have powerful anti-inflammatory benefits. Its findings are significant because glucocorticoid hormones – also known as steroids – are [...]

By |2017-12-13T10:22:21+00:00December 13th, 2017|Community Pharmacy|Comments Off on Steroid Study Sheds Light on Long-Term Side-Effects of Medicines

First Short-Acting ‘Follow-on’ Insulin Product to Treat Diabetes

The US Food and Drug Administration (FDA) has approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and paediatric patients aged three years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus. Admelog is the first short-acting insulin approved as a [...]

By |2017-12-13T10:21:05+00:00December 13th, 2017|Industry News|Comments Off on First Short-Acting ‘Follow-on’ Insulin Product to Treat Diabetes

Synthetic Cannabis-Like Drug Reduces Sleep Apnea

A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health. The study was conducted at Northwestern Medicine and the University of Illinois at Chicago (UIC). There’s currently no drug treatment for [...]

By |2017-12-06T11:23:44+00:00December 6th, 2017|Community Pharmacy|Comments Off on Synthetic Cannabis-Like Drug Reduces Sleep Apnea

Using Social Media Big Data to Combat Prescription Drug Crisis

Researchers at Dartmouth, Stanford University, and IBM Research, conducted a critical review of existing literature to determine whether social media big data can be used to understand communication and behavioural patterns related to prescription drug abuse. Their study found that with proper research methods and attention to privacy and ethical issues, social media big data [...]

By |2017-12-06T11:31:14+00:00December 6th, 2017|Community Pharmacy|Comments Off on Using Social Media Big Data to Combat Prescription Drug Crisis

Pharmacists Urged to Take New Winter Asthma Action

As temperatures in the UK plummet – putting four million people with asthma at risk of life-threatening asthma attacks – Asthma UK is urging pharmacists to get behind its #Scarfie campaign, where ‘a scarf could save a life’. Cold air is a major trigger for asthma attacks, with 75 per cent of the 5.4 million [...]

By |2017-12-06T11:26:25+00:00December 6th, 2017|Community Pharmacy|Comments Off on Pharmacists Urged to Take New Winter Asthma Action